Zhejiang Sunflower Great Health Co., Ltd. (SHE:300111)

China flag China · Delayed Price · Currency is CNY
4.490
+0.030 (0.67%)
At close: Mar 10, 2026
46.73%
Market Cap 5.78B
Revenue (ttm) 302.92M
Net Income (ttm) 6.35M
Shares Out 1.29B
EPS (ttm) 0.01
PE Ratio 910.42
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,005,300
Average Volume 46,625,614
Open 4.530
Previous Close 4.460
Day's Range 4.460 - 4.600
52-Week Range 2.330 - 10.280
Beta 0.54
RSI 42.47
Earnings Date Apr 22, 2026

About SHE:300111

Zhejiang Sunflower Great Health Co., Ltd. engages in the research, development, production, and sale of anti-infectious, cardiovascular, digestive system and other drugs in China and internationally. It offers clarithromycin API and tablets, anti-infective drugs used for nasopharyngeal infection, lower respiratory tract infection, skin and soft tissue infection, acute otitis media, Mycoplasma pneumonia, and urethritis and cervicitis; and azithromycin dispersible tablets and injections for sinusitis, acute otitis media, acute bronchitis, acute e... [Read more]

Sector Healthcare
Founded 2005
Employees 331
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300111
Full Company Profile

Financial Performance

In 2024, SHE:300111's revenue was 330.37 million, a decrease of -2.38% compared to the previous year's 338.42 million. Earnings were 7.83 million, a decrease of -64.01%.

Financial Statements

News

There is no news available yet.